Subscribe To
Kineta Appoints Internationally-Renowned Clinical Immuno-oncology Experts to its Scientific Advisory Board
SEATTLE, March 01, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on developing next-generation immunotherapies to address cancer immune resistance, announced today the appointment of Myriam Chalabi, M.D. and Evan Ya-Wen Yu, M.D. to the company’s immuno-oncology focused Scientific Advisory Board (SAB). Dr. Chalabi and Dr. Yu will join Kineta’s […] The post Kineta Appoints Internationally-Renowned Clinical Immuno-oncology Experts to its Scientifi...
Read More
Posted: Mar 1 2023, 11:30
Author Name: forextv
Views: 110849